Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Implementation of a Novel, Resident-Led, Nocturnal Curriculum.

Golbus JR, Manly DA, Wonneberger KA, Hanff TC, Murphy KM, Wang DS, McKee SG, Bellini L.

J Grad Med Educ. 2015 Sep;7(3):417-21. doi: 10.4300/JGME-D-14-00735.1.

2.

Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation.

Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, Mackman N, Green R, Liebman HA.

Thromb Res. 2012 Sep;130(3):361-8. doi: 10.1016/j.thromres.2012.04.001. Epub 2012 Apr 28.

PMID:
22542362
3.

Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.

van Doormaal F, Kleinjan A, Berckmans RJ, Mackman N, Manly D, Kamphuisen PW, Richel DJ, B├╝ller HR, Sturk A, Nieuwland R.

Thromb Haemost. 2012 Jul;108(1):160-5. doi: 10.1160/TH12-02-0099. Epub 2012 Apr 26.

PMID:
22535219
4.

Nothing to sneeze at.

Manly D.

CMAJ. 2011 Nov 22;183(17):E1239-40. doi: 10.1503/cmaj.109-4015. Epub 2011 Oct 31. No abstract available.

5.

Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.

Lee RD, Barcel DA, Williams JC, Wang JG, Boles JC, Manly DA, Key NS, Mackman N.

Thromb Res. 2012 Jan;129(1):80-5. doi: 10.1016/j.thromres.2011.06.004. Epub 2011 Jul 6.

6.

Role of tissue factor in venous thrombosis.

Manly DA, Boles J, Mackman N.

Annu Rev Physiol. 2011;73:515-25. doi: 10.1146/annurev-physiol-042210-121137. Review.

7.

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.

Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, Mackman N.

Thromb Res. 2010 Jun;125(6):511-2. doi: 10.1016/j.thromres.2009.09.019. Epub 2009 Oct 24.

8.

Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice.

Wang JG, Manly D, Kirchhofer D, Pawlinski R, Mackman N.

J Thromb Haemost. 2009 Jul;7(7):1092-8. doi: 10.1111/j.1538-7836.2009.03448.x. Epub 2009 Apr 27.

9.

Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay.

Ollivier V, Wang J, Manly D, Machlus KR, Wolberg AS, Jandrot-Perrus M, Mackman N.

Thromb Res. 2010 Jan;125(1):90-6. doi: 10.1016/j.thromres.2009.03.003. Epub 2009 Apr 5.

10.

US biovigilance network to track donor-derived infections.

Manly D.

CMAJ. 2009 Feb 17;180(4):382. doi: 10.1503/cmaj.090064. No abstract available.

11.

Efficiency of the stimulus characteristics of ECT.

Swartz CM, Manly DT.

Am J Psychiatry. 2000 Sep;157(9):1504-6.

PMID:
10964870
12.

Electroconvulsive therapy in old-old patients.

Manly DT, Oakley SP Jr, Bloch RM.

Am J Geriatr Psychiatry. 2000 Summer;8(3):232-6.

PMID:
10910422
13.

Endpoint of ECT-induced elevation in heart rate.

Swartz CM, Manly DT.

J ECT. 1999 Jun;15(2):125-8.

PMID:
10378151
15.

Dissociation precipitated by propranolol.

Finestone DH, Manly DT.

Psychosomatics. 1994 Jan-Feb;35(1):83-7. No abstract available.

PMID:
8134534
16.

Influence of divalent and monovalent cations on some active site properties of human factor Xa.

Manly DT, Featherstone GL, Jenzano JW, Roberts HR, Lundblad RL.

Thromb Res. 1988 Feb 1;49(3):343-51.

PMID:
3163182

Supplemental Content

Support Center